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Paulson, Daryl S., M.S., 1977

Microbiology

Some ancifungal activities of guinea pig peritoneal exudate cells against
Sporothrix schenckii. (46 pp.)
Director;

John J. Taylor

Six guinea pig models were treated with
schenckii conidia in various
combinations to ascertain the effects of peritoneal exudate cells (PECs)
on these conidia, to find whether or not those PEC effects were fungicidal
or fungistatic to _S. schenckii conidia, and to determine the effects
hydrocortisone acetate compromise had upon PEC activity. Phagocytic res
ponses were measured using these 6 animal models which included animals
immunized with viable conidia, animals immunized with non-viable conidia,
untreated controls, animals compromised with cortisone but not immunized,
animals both compromised and immunized with viable conidia and finally
animals both compromised and immunized with non-viable conidia.
Statisti
cal analyses were used to compare the groups. It appears that animals
immunized with viable conidia are more efficient in clearing these fungi
via phagocytosis, that phagocytic rate and fungicidal properties are posi
tively correlated, and that cortisone compromise, achieved through repeated
cortisone injections into these animals, reduces both phagocytic ability
and fungicidal properties to PECs.
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CHAPTER I

INTRODUCTION
A. BASIC REVIEW MATERIAL
Host/Parasite Relationship
For man and other animals, parasitic microbial Infection Is the
Invasion

of the host’s tissue by a multiplying microorganism which

consumes the host’s nutrients, placing a strain on the host’s homeostatic
ability.

However, through the course of evolution, several effective

and efficient antimicrobial defense systems have evolved:

the Immune

system and the reticuloendothelial system which are Interfunctional.
Immune Sys tem
The immune system(47) composed of primary and secondary lymphoid
tissue (spleen, thymus, lymph nodes, bone marrow, lymphocytes and Peyer’s
patches) can be further divided into two cell type systems:
and the cellular Immune systems.

the humoral

The humoral system refers to those

lymphoid cells whose primary function is to produce antibodies (glyco
proteins) capable of binding non-covalently through electrostatic forces,
van der Walls force, hydrogen bonding of hydrophobic/hydrophilic Inter
actions with specific complementary antigens.

These humoral cells (B cells)

are bone marrow derived and are the precursor cells of Immunoglobulin
secreting cells or plasma cells.

The cellular lymphoid system consists of

thymus derived lymphoid cells (T cells), which do not differentiate Into
immunoglobulin secreting cells, but Instead produce lymphokines such as
macrophage activation factors, macrophage inhibition factors, lymphocytotoxlns. Interferon, activation factors for eliciting the humoral
Immune response and chemotactic factors.

-

They are responsible for hetero-

1

-
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genous tissue graft rejection, they have the ability to directly lyse
and destroy foreign cells Including certain tumors, and they are Involved
In delayed hypersensitivity reactions.
Reticuloendothelial System
The reticuloendothelial system(5,44) Is composed of a network of highly
phagocytic reticular cells lining organ tissues such as the spleen, the
thymus, the liver (Kupffer’s
tunica interna.

cells) and the vascular endothelium of the

In addition to these sessile cells, motile phagocytic

cells occur In the peripheral pools as neutrophils, basophils, eosinophils,
and monocytes.

The macrophage, the end cell of the monocyte line and the

phagocyte found In various tissue, Is free to wander by ameboid movement
through tissue.

It is especially concentrated within the loose connective

tissue, but Is not restricted to that tissue.

Specialized macrophages are

found In the alveoli of the lungs (alveolar macrophages) and In the
peritoneal cavity as peritoneal macrophages.
Peritoneal Exudate Cells
The cells of special Interest In this thesis are the peritoneal exu
date cells (PEC) which Include PMNs, monocyte/macrophages, and lymphocytes
but particularly the macrophage since It Is the most abundant cell normally
found In the extravascular area of the peritoneal cavity.
Macrophage:

The macrophage, derived from the circulating white blood

cell, the monocyte. Is a long lived and a very effective phagocytic cell
In mammals(13,39,42).

Electron microscopy has revealed that a unit mem

brane exists In the macrophage which has many protuberances (microvilli)
and Invaginations.
reticulum.

The cytoplasm contains smooth and rough endoplasmic

IVo types of vacuoles have been shown to exist:

a smaller
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pinocytic vesicle and a larger phagocytic vacuole.
particles smaller than

0

The macrophage ingests

.1 pm by pinocytosis and engulfs particles of

larger size through phagocytosis.

It has a plasma membrane which is capable

of recongnizing two of four subclasses of the human gamma immunoglobulin
class, IgG^ and IgGg which differ only in their physicochemical composition
in the constant globulin region(4).
fraction C3b.

It can also recognize the complement

The macrophage has been shown to be capable of both non-

immunologically and immunologically controlled phagocytesis/pinocytosis.
The macrophage has also been shown to attach to the Fc portion of
the gamma immunoglobulin, which has previously been bound to an antigen.
During phagocytosis, a particle is bound to the macrophage’s membranee
receptors and surrounded by the cell membrane.

The particle is then

internalized into a phagosome and finally digested after the phagosome
containing the particle and a lysosome have been fused(45).
Metabolism of the macrophage is dependent upon the activation state
of the cell.

An unactivated macrophage obtains energy primarily through

anaerobic glycolysis but the activated macrophage has a significant increase
in the hexose monophosphate shunt-

A macrophage may become activated by

exposure to lymphokines produced by sensitized T cells or by direct antigen
contact.

An activated macrophage is larger than the unactivated form, an

activated macrophage adheres to glass more readily than an unactivated
macrophage, and an activated macrophage is more phagocytic than an unact
ivated type especially in phagocytosing complement-coated C3b, or IgG^ and
IgGj coated particles.

An activated macrophage also exhibits a greater

chemotactic ability than the non-activated type.
Mechanisms of intracellular killing are not as well known in macrophages
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as in neutrophilic degradation involving myeloperoxidase» an acid pH, a
halogen, and hydrogen peroxide.

However, lysozyme and hydrogen peroxide

are known to be of importance in the killing and degradationability by
the macrophage.
The killing effect of the macrophage is related to the engulfed
particle's chemical structure and to the activation of the macrophage.
The activated macrophage is especially efficacious in phagocytosing intra
cellular organisms.
Neutrophil;

The neutrophil, a phagocytic leukocyte(8 ), is also

important as a PEC.

The neutrophil, a polymorphonuclear leukocyte,

accounts for about 60% of the total number of white blood cells contained
in the peripheral blood pool, and is of secondary importance to the macro
phage in this thesis only because it is not the major phagocytic cell
line found in the peritoneal cavity.

The neutrophil is a key cell in the

phagocytic defense system because of its phagocytic effectiveness and
efficiency and its quick response to microbial pathogens.
The neutrophil is 10-2Qium in diameter and is distinguished by its
3-to-5 lobed nucleus held together by the nuclear envelope.

Its average

life span is 4 to 5 days and therefore, it is a short-lived cell.

The

neutrophil is extremely motile via ameboid movement and may become
.chemotactic in the presence of certain attracting microbial products,
tissue proteases, and C3b and C4b complement components.

Opsonized micro

bial organisms are more readily phagocytosed than non-opsonized ones and
neutrophils having surface Fc receptors which recognize opsonins are very
effective in phagocytosing opsonized microbial organisms in one of three
ways(5,12):

(1) by a specific IgG antibody/antigen complex; (2) by a
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specific IgG antibody/complement complex; or (3) by a non-specific compiiement
fraction activated by a bacterial or fungal polysaccharide which forms iaii
microbe/complement complex evoking phagocytosis.

>ln

Phagocytosis of microbial organisms Is also educed by three additional
factors:

(1 ) by the proximity of an antigen and a neutrophil relative tmC

each other since the more packed together they are, the greater the pha*d
gocytlc activity Independent of chemotactic or opsonizing factors; (2)>r t
through natural antibodies other than IgG molecules synthesized for spœn?Iflc antigens ; and (3) through leukoklnln, a type of IgG complex which

Ic

can coat the neutrophil’s surface stimulating neutrophilic phagocytoslsicu
Ostensibly, the biological activity of leukoklnln Is dependent upon a

Iv'j

single peptide chain (Thr-Lys-Pro-Arg) named Tuftsin since It was dlsco%sred at Tufts University(25).
The energy requisite for the neutrophil’s killing mechanism Is proch,'
vlded by the glycolytic pathway.

This pathway Is significant because

neutrophilic phagocytosis often occurs In hypoxic surroundings such as n o
abscessed lesions.
Once a microbe and a neutrophil have made contact, pseudopodia

rop

from the neutrophil extend and fuse on the far side of the microbe, encs&TIng It within a phagosome.

The phagosome containing the microbe moves a p

toward the cell’s center where It fuses with lysosomes (at a low p H ) ■coiâi
talnlng myeloperoxidase, hydrogen peroxide, and a halide.

Once fusion gif'

these constituents has been completed, the microbe Is killed and degradiqd!.
This Is an especially effective mechanism In phagocytic removal of
Intercellular pathogens.
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B.

SPECIFIC REVIEW MATERIAL

Three Host/Parasite Models
Bacterial Model:

The polymorphonuclear leukocyte is usually the first

cell to provide defense against pathogenic bacteria(4).

Upon entry into

a host, specific bacterial end products are chemotactic for neutrophils.
Once a neutrophil has come in contact with a bacterial cell, the bacterium
is phagocytosed.

The phagocytic efficiency is enhanced if the bacterial

cell has been previously opsonized, for example, by IgG antibody.
If the bacterial pathogen is a long-lived and/or an intracellular
organism, the activated macrophage is more effective in its removal than
the neutrophil.

Mackaness(34) studied extensively the macrophage's role

in intracullular bacterial infection.
sub-lethal dose of virulent Listeria

He introduced, intravenously, a
monocytogenes into a mouse model

and ascertained that it was initially removed by neutrophils and sessile
cells of the reticuloendothelial system.

However,

monocytogenes was

found to continue multiplying in these cells for 3 to 4 days after being
phagocytosed.

But after the 4th day, the bacterial population dropped

off rapidly until

monocytogenes was eliminated from the infected mice.

The mice proved to be highly resistant to a rechallenge of these bacteria
and suffered no pathological effects with a rechallenge of up to a LD^ q
dose of

monocytogenes.

The reason for the high level of resistance was that the bacterial
antigens stimulated the cellular immune system, elicited by the T lympho
cytes, between the 1st and 2nd days of the challenge.

The sensitized T

cells released lymphokines such as macrophage activation factors and
macrophage inhibition factors into the area where the T lymphocytes and
bacterial cells interacted.

The lymphokines activated the macrophages
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and they readily phagocytosed the bacteria.

Resistance to

monocytogenes

was long-lived in these mice due to the T memory cells which were capable
of reactivating the macrophages upon a rechallenge and subsequent recogni
tion of

monocytogenes.

A different bacterial model, Mycobacterium tuberculosis, a long-lived,
acid fast bacterium and the causative agent of tuberculosis, has provided
similar results.

With low level doses of M. tuberculosis in healthy, well

nourished mammals, the disease is usually averted through neutrophilic
phagocytosis.

However, when M. tuberculosis is not completely destroyed

by neutrophils, the activated macrophages become a preeminent factor in
the phagocytosis of these bacteria.
In 1965, Lurie and Dannenburg(32), using inbred rabbits as hosts,
studied macronhage/M. tuberculosis interaction.

They concluded that resis

tance or susceptibility to tuberculosis in the rabbits was dependent on
the macrophage’s phagocytosing ability.

In addition, when they injected

cortisone into these rabbits, they found that the cortisone (which they
thought prevented the fusion

of the macrophage’s phagosome and lysosome

bodies) severely reduced the macrophage’s ability to eliminate ^
However, Hart and Armstrong(18) reported in 1974 that

tuberculosis,

tuberculosis survived

degradation in their study, even after being phagocytosed and both the
phagosomal and lysosomal bodies had in fact fused.
Moreover, it had previously been shown in several studies that the
cellular immune system accounted for a major portion of the phagocytic
elimination of M. tuberculosis.

For example, in 1960, Hsu and Kapral(25)

compared guinea pig immune peritoneal macrophages with non-immune periton
eal macrophages.

They concluded that the immune and therefore activated

macrophages were more effective in phagocytosing

tuberculosis than

non-immune macrophages
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Youmans and Youmans in 1969(48) reported that M. tuberculosis was
not only eliminated faster by immunized (activated) macrophages than by
non-activated macrophages, but the activated macrophages, immunized
specifically for ^

tuberculosis were as expeditious in removing non

related organisms such as Lj_ monocytogenes as those macrophages sensitized
with

monocytogenes.
In a bacterial model using Salmonella typhimurium, a gram negative

bacterium the causative agent of salmonella gastroenteritis, several
studies (3,35) concluded that macrophages activated by T lymphocytes were
more efficient in killing S . typhimurium than non-activated macrophages.
Also, it was reported that humoral components (B cells) were not a sign
ificant factor in the activation of the macrophages against _S_j_ typhimurium.
Viral Model;

Since viral infections are intracellular, macrophages

may have an antiviral function in this type of infection (2,37).

T

lymphocytes, upon recognition of viral antigen, release lymphokines which
in turn activate macrophages.
the free virus particles.

These activated macrophages then pinocytose

It has been demonstrated in vitro that activated

macrophages do restrict intracellular replication of some viruses through
phagocytoses.

It has also been shown that activated macrophages protect

new born mice from herpesvirus infection(19).

There is evidence that

macrophage-produced interferon offers resistance to general viral infections;
however, no conclusive evidence has been shown to date.
Fungal Model:

Studies pertaining to subcutaneous and systemic fungal

infections in mammalian hosts have been neglected, for the most part, rela
tive to the extensive and intensive studies conducted upon bacterial and
viral models.

One reason for this is the low invasiveness many fungi have

upon healthy and well nourished mammals.

However, with the advent of
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broad-spectrum antibiotics, synthetic anti-inflammatory drugs such as the
corticosteroids, and present oncological treatment methods (eg. chemo
therapy), the occurrence of fungal diseases such as candidiasis, mucoirmycosis, cryptococcosis, and aspergillosis has been increasing significantly
(29.45).
Natural resistance appears to be a major factor in protecting the
host against pathogenic subcutaneous and systemic fungal infections.
Neutrophils rapidly provide initial protection against these organisms
until the macrophages become activated.

Once activated, macrophages can

be effective antifungal agents especially in, for example, fungal infect
ions like Cryptococcus neoformans.
Early attempts(28) in 1925 by Shapiro and Neal and Hoff in 1942, and
Macus and Rambo(36) in 1955 failed to find an immunization treatment for
or an immune mechanism to explain cryptococcosis relative to the humoral
immune system.
Gadebush(14) in 1958, provided an interpretation of natural immunity
against Cj_ neoformans in rabbits which was accepted as valid.
duced C . neoformans into rabbits through aerosols.

He intro

Once C. neoformans

was situated in the alveolar septa and the alveoli of the lungs, the
majority was removed within 24 hours by neutrophils.

However, the fungi

that were not phagocytosed by neutrophils proliferated freely.
cytic obligation soon shifted to the monocyte.

The phago

It is thought that during

this shift the fungi spread into areas outside the pulmonary tract(15).
After several days, the monocytes which initially confronted C_^ neoformans
matured into macrophages.

They and other macrophages were activated by

delayed hypersensitivity reactions as both an effect of the cellular
immune response and through previous contact with the fungi as monocytes.
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i.e., direct contact activation.

The existing C. neoformans were then

swiftly phagocytosed and destroyed.
was common if the infective

Complete recovery from this infection

neoformans dose was not so massive as to

overwhelm the host*s system.
Abrahams (1) in 1966 demonstrated that natural resistance to crypto
coccosis in mice was dependent on the cellular immune system and not the
humoral system directly.

However, it was demonstrated that opsonization

of these fungi by IgG greatly enhanced phagocytosis.

Abraham’s findings

were supported by Goren(17) in 1967.
Rabbit Macrophage;

In previous study in our laboratory(11) it was

found that alveolar macrophages may be activated by either viable or nonviable

schenckii conidia regardless of the route of administration.

It was discovered that fungicidal activity was 2-to-3 fold greater in
those macrophages which had been recovered from animals sensitized by
aerosols than from those sensitized by intramuscular, intravenous, or
intraperitoneal injections of equivalent numbers of conidia.
S. schenckii Neutrophil Model:

In 1973, Howard(23), using guinea

pig neutrophil cell cultures, demonstrated that neutrophils were highly
effective in killing extracellular Histoplasma capsulatum fungi cells.
Other studies (24) have also <^hown that neutrophils are highly effective
against certain extracellular fungi, such as Candida albicans, krusei,
parapsilosis, stellatordia, pseudotropicalis. Saccharomyces cerevisiate,
Geotrichium canidium, Aspergillus niger, fumigatus, and neoformans.
Macrophage Model:

Howard(20), in 1959 maintained normal (noniramune)

mouse peritoneal exudate macrophage cultures inoculated with yeast phase
H. capsulatum.

He found that as few as 30 fungus cells per macrophage

overwhelmed the macrophages.
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In 1965, Howard(21) expanded his previous studies dealing with
nonimmune mouse macrophages to other models.
isolates of

He used five different

capsulatum; he used both guinea pig and mouse normal

macrophages, and he used guinea pig and mouse macrophages in the pre
sence of specific hyperimmune serum and macrophage cells from specific
ally immunized guinea pigs and mice.

He concluded that the generation

time of H^ capsulatum in mammalian macrophages was very constant, that
the rate of growth for the five

11^

capsulatum isolates was very similar

in macrophage cells; that the generation time of fungus within guinea
pig macrophages was nearly the same as in mouse macrophages, and that
the exposure of yeast phase H^ capsulatum to antibody and complement
did not affect intracellular fungal proliferation in the macrophages.
He reported no significant difference in fungus proliferation within
macrophage cells from immunized compared with those from nonimmunized
guinea pigs and mice.
In 1973 Howard(22) used freshly harvested macrophages from immunized
mice instead of those grown on tissue cultures.

He found that H. capsulatum

was inhibited by these immune activated macrophage cells but was not killed.
In 1976 Howard and Otto(24) reported that the effectiveness of inhibit
ion of _H^ capsulatum was a product of the cellular immune system and not
the humoral system.
Kashkin et al.(27) in 1976, using the pathogenic fungi Coccidioides
immitis, the causative agent of the pulmonary infection coccidioidomycosis,
reported a similar finding that fungicidal and fungistatic responses are
dependent upon the cellular immune system which activated the peritoneal
macrophages.

This is important to this author's research in that the

fungicidal and fungistatic effects of the cellular immune system against

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

—12—

S. schenckii shall be studied.
Statement of Purpose
This author proposes a slightly different approach In continuing
pathogenic fungal .research.

The previously cited fungal models used

fungi that are not normally encountered by peritoneal exudate cells,
particularly peritoneal macrophages.

capsulatum. C. neoformans. and

G. Immltls are basically pathogenic to the pulmonary system.

To date

no study concerning a subcutaneous fungus/PEC model has been reported.
Hence, It Is felt that a guinea pig model using

schenckii would be

of significance since peritoneal exudate cells do normally encounter
subcutaneous pathogenic fungi.
Therefore, the purpose of this thesis Is to determine some anti
fungal properties of guinea pig peritoneal exudate cells when chal
lenged by the pathogenic fungus, S_^ schenckii. the causative agent of
sporotrichosis, a lymphocutaneous Infection.
The first question to be evaluated Is:

what phagocytic effects. If

any, do guinea pig peritoneal exudate cells have upon ^
The second question to be evaluated Is:

schenckii?

given phagocytosis does

occur. Is It fungistatic or is It fungicidal?
The thlru questions to be evaluated Is:

what are the effects of

cortisone compromise on PEC activity?
Plan of Development
In this study, ^

schenckii conidia will challenge thloglycolate-

Induced guinea pig peritoneal exudate cells In three specific modes:
normal. Immune, and Immune suppressed.
1.

Normal condition:

exposure to S. schenckii.

Defined as a guinea pig having had no previous
This is also the control condition.
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2.

Immunized condition:

Defined as a guinea pig having been immu-

nized for both a primary and a secondary response against S. schenckii
antigens and therefore presumably capable of antigenic memory and macro
phage activation.
3.

Immune suppressed condition:

Defined as the state in which the

capacity to elicit the immune response has been greatly reduced by the
use of corticosteroids.
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CHAPTER II

MATERIALS AND METHODS

Animal Models
Guinea pigs, the animals models used in this research, were obtained
from Rocky Mountain Laboratories, Hamilton, Montana, were housed in the
animal room at the Department of Microbiology, were approximately the
same age, were immune competent, and were fed a nutritionally complete
commercial guinea pig ration.
Fungal Cultures
Cultures of ^

schenckii, strain 425, were obtained from stock cultures

stored at the Department of Microbiology, University of Montana.
tures of

Subcul

schenckii were inoculated onto Mycosel agar (Baltimore Biolo

gical Laboratory) slants; were incubated in screw cap tubes at 25°C, and
stored at minus 20°C.

Before any S_^ schenckii culture was employed, the

culture was examined for contamination through microscopy and gross
observation.

Broth cultures used for harvesting condia contained 150 ml

Sabouraud dextrose broth (Difco Laboratories) combined with 0.1% yeast
extract (Difco Laboratories).

For conidia harvesting, a subculture of S.

schenckii was streaked on a Mycosel agar plate, which was incubated at 25°C
for 96 hours.

After incubation, a 0.5 X 0.5 mm section of agar containing

S. schenckii was removed and inoculated into a 500 ml Erlenmeyer flask con
taining 150 ml of the conidia broth described above.

Each inoculated flask

was then incubated at room temperature on a horizontal shaker for
12 days.

10

to

At this time, the conidia were harvested by transferring about

75 ml of each broth culture into a 250 ml sterile plastic centrifuge bottle.
The bottles were centrifuged at 75 x G, at 4°C, for 10 minutes and the
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supernatant was discarded, leaving In each centrifuge bottle a pellet mass
of conidia.

To each of the plastic centrifuge bottles, 100 ml of sterile

physiological saline (0.85%) were added.

The bottles were hand agitated

25 times to Insure an adequate washing of the conidia.

The conidia were

then recentrifuged as previously described and after centrifugation, a
second conidia washing was performed.

These washed conidia were stored

In the plastic centrifuge bottles at minus 20°C for future use as either
cellular antigens or for use In establishing the effectiveness of PEC
phagocytosis In vitro.
Tissue Culturing Media
Eagles Minimum Essential Media (MEM) with Earles' balanced salt
solution (Microbiological Associates) was the tissue culture medium
employed.

Two grams crystalline MEM were reconstituted In 1,000 ml triple

distilled water, buffered with

2.2

grams NaHCO^, and the hydrogen Ion

content was adjusted to pH 7.2 using 1 N NaOH or 1 N HCl depending upon
the acid or base concentration.

This completed medium was filter steri

lized using a Seitz filter, pore size 0.22fim and stored at 4°C.
For the tissue culturing process, 100 ml MEM was enriched with 2%
heat Inactivated fetal calf serum (Microbiological Associates), 1 ml
trlclne (Sigma Chemical Co.) as a buffering agent, 10,000 units penicillin
G (Sigma Chemical Co.) and 10,000 pg streptomycin sulfate (Sigma Chemical
Co.) each to Inhibit gram positive and gram negative bacterial growth
respectively, 1 ml heparin (Sigma Chemical Co.) to prevent clumping of
red blood cells and 1 ml L-glutamlne (Sigma Chemical Co.) to ensure ade
quate levels of this amino acid.

In this thesis, this solution shall be

known as complete MEM.
Phosphate Buffered Saline (PBS) was utilized as a physiological buffer-
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ing agent and in the tissue culture washing process to be described later.
Stock solutions of PBS were prepared as described by Dulbecco and Vozt(9).
Glassware
All glass items utilized in this work were first rinsed in cool water
to avoid protein coagulation, then washed in warm soapy water, rinsed 5
times in distilled water, and finally acid rinsed for a minimum of 4 hours
in a 0.1 N HCl immersion bath.

In cases where direct contact between PECs

and glassware occurred, those glasswares were siliconized with Silaclad
(Biological Associates) with the exception of the 15 mm-diameter cover
slips positioned in the bottom of each culture well in order to augment
PEC adherence.
Antigen Preparations
Two types of cellular antigens were used in this work; viable and
non-viable S. schenckii.
of

(1) Viable S. schenckii;

As required, samples

schenckii conidia were transferred from the 250-ml plastic centri

fuge bottles, plated on Mycosel agar, incubated at 25°C, and inspected
for growth on the 5th day of incubation in order to ensure viability.
Preparations of viable conidia were produced by adding conidia to sterile
physiological saline until a concentration of
was achieved.

10^

conidia per ml saline

These viable conidia preparations were stored at 4°C in

screw cap bottles.

(2) Non-viable S. schenckii:

conidia were added to a

1

S. schenckii viable

:1 0 , 0 0 0 concentration of merthiolate, incubated

at 35°C for 24 hours and washed in PBS to remove the merthiolate.

This was

accomplished by centrifuging the merthiolate aliquot for 15 minutes at 4®C,
at 75 X G.

Once completed, the merthiolate supernatant was decanted

followed by the addition of 50 ml PBS.

This mixture was hand agitated 25

times to ensure adequate washing, followed by recentrifugation as previously
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described.

At this time, a sample of the conidia from this washed

aliquot was plated on Mycosel agar, incubated at 25°C, and inspected
for growth after 72 hours.

Non-viability was validated by the absence

of any conidia growth when plated on Mycosel agar.
were also stored at a

10^

Non-viable conidia

conidia per ml physiological saline concen

tration at 4°C in screw cap bottles.
Experimental Models
Group I :

This, the control group, received neither an immunization

of fungal conidial antigen or cortisone.
Group II;

This group was immunized with merthiolate-treated, non-

viable S_^ schenckiL conidia.

The guinea pigs in this group were initially

immunized intraperitoneally at day

1

with a

10^

conidia dose followed by

a second 10^ conidia dose at day 11, and the PECs were extraced at day 22.
Group III:
viable conidia.
first at day

1

The animals in this group were immunized with

schenckii

Each animal received two 10^ doses of viable conidia, the
and the second at day

11,

administered intraperitoneally.

PECs were collected at day 22.
Group IV:

The guinea pigs in this group were administered hydro

cortisone acetate (Sigma Chemical Co.) but no fungal antigen.

Each animal

received 0.05 mg hydio-cortisone acetate (cortisone) per gram body weight
intraperitoneally at 5-day intervals until day 22.

At this time the PECs

were removed.
Group V:

This group was treated with cortisone and immunized with

non-viable _S^ schenckii conidia.

Two days prior to the first 10^ non-

viable conidia immunization, 0.05 mg cortisone per gram body weight was
injected intraperitoneally into each guinea pig; the injection was repeated
at 5-day intervals until day 22.

Non-viable conidia in a 10^ dose were
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injected into each animal at days

1

and

11,

followed at day

22

with the

collection of PECs.
Group VI:
viable ^

This group was injected with cortisone and immunized with

Schenckii conidia.

Guinea pigs received 0.05 mg dose of cortisone

per gram body weight intraperitoneally
of 10^ viable conidia.

2

days prior to the first immunization

Cortisone was readministered at 5-day intervals

thereafter until day 22.

At days 1 and 11, non-viable conidia were

injected into each guinea pig intraperitoneally and at day 22 the PECs were
collected.
It should be mentioned that in each of these

6

models, 72 hours prior

to removal of the PECs (or on day 19), each guinea pig was induced with an
injection of 4 ml of thioglycolate fluid medium (Difco Laboratories) intra
peritoneally.
In Vitro Methodology
In order to study the in vitro effects of PECs when exposed to S.
schenckii conidia, PECs were introduced to viable conidia through a tissue
culturing procedure.
Procedure
1.

At day 22, 20 ml complete MEM was injected intraperitoneally via

an 18 gauge needle into each guinea pig.

This was followed by a gentle

massage of the abdominal area for approximately
number of PECs collected.

1

minute to increase the

At this time the needle was removed from its

syringe and replaced, bevel up, into the initial puncture wound at an acute
angle of 20-40° from the plane of the guinea pig's abdomen until it was in
the peritoneal cavity.

A prechilled 40-ml sterile siliconized centrifuge

tube was held under the needle's butt to collect the returning PEC suspension.
To ensure the maximum recovery of the PEC suspension, a gentle downward
abdomen milking was provided each animal.
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2.

After the PEC/MEM aspirates were collected from each of the six

guinea pig models, they were centrifuged 5 minutes, at 4°C, at 75 X G,
in the 40-ml centrifuge tubes.
3.

Once centrifugation was completed, the supernatant was aspirated,

leaving a pellet of PECs at the bottom of each of the tubes.

At this point

1 ml 9.17 M Tris-(hydroxymethyl)-aminomethane (Sigma Chemical Co.) and 9 ml
0.83% NH^Cl were added to each centrifuge tube containing the PECs.

This

suspension was allowed to stand at room temperature for 15 minutes to en
sure lysis of any red blood cells collected.
4.

The cells were then re-centrifuged as in step 2 followed by aspi

ration of the supernatant fluid.

Once completed, 10 ml PBS were added to

each centrifuge tube to wash the PECs, followed by centrifugation as in
step

2

.

5.

At this point, the supernatant was aspirated and the PECs were

resuspended in 5 ml of complete MEM per each centrifuge tube.

A small

volume of PEC/MEM suspension from each tube was collected and placed on
a hemocytometer.

The PECs were then counted by standard methods(4) and

these counts estimated the number of PECs per ml within the tubes.
Complete MEM was added to each of the 40-ml centrifuge tubes until a 10^
PEC count per ml was confirmed via counting.
6

.

After a uniform cell count of 10^ cells per ml was achieved for

each of the

6

models, 1 ml PEC aliquots were added to each of the 24, 1.7

X 1.6 cm wells contained in each flat bottom tissue culture plate (Flow
Laboratories).

Each well in tissue culture plates contained a round 15

mm flat non-siliconized glass cover slip for PEC adherence.
7.

These tissue culture plates were incubated at 37°C in 0.4% CO^

for 45 minutes.

At this time any non-adherent PECs within each culture

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

— 20-

well were removed by dispensing 5 ml PBS into each well simultaneously
removing the PBS/MEM solution through a Pasteur pipette via negative
pressure.

To prevent the PECs from osmotic shock, approximately a 2 mm

layer of PBS covering the adherent cells on the coverslips was not
removed.

Quickly, 1 ml of MEM was reintroduced into each of the tissue

culture wells.
incubated.

Once completed, the PEC tissue culture plates were re

Refeeding was performed every 4 hours in an identical manner

until the PECs had been cultured for a total of 12 hours.

It was found

that 12 hours incubation was necessary for an even monolayer of PECs to
form on each of the cover slips.
8

.

At hour 12, each of the tissue culture wells was washed with 5

ml PBC as stated in step 2, followed by the introduction of 10“^ viable
S. schenckii conidia suspended in 1 ml of complete MEM.
9.

At times 0, h, %, 1, 2, 4,

8

, and 12 hours, a cover slip con

taining adherent PECs, representing each of the

6

models, was removed

from the appropriate tissue culture well, washed in physiological (0.85%)
saline, and stained with a

1

:1 0 , 0 0 0 dilution of acridine orange in a

modified procedure described by Newcomer(40).

Following the acridine

orange staining method, conidia which are viable appear bright green while
conidia which are non-viable appear orange or red when examined with fluo
rescence microscopy.
10.

Two methods of conidia counting were employed.

In the first

method, 20 PECs, selected at random, were observed microscopically.
number of conidia contained within each of these
lated and averaged.

20

The

phagocytes was tabu

The second counting method used the same data as the

first except any of the PECs not actually demonstrating phagocytoses via
the acridine staining method were dropped from the tally and an adjusted
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average number of conidia phagocytosed per PEC was calculated.

This was

performed in order to allow for the possibility that the PECs which did
not demonstrate intracellular conidia may have been non-viable PECs
instead of viable, non-phagocytosing PECs.
Quantitative Analysis
The Statistical Package for Social Science (SPSS) computer program
format was employed on the University of Montana’s DEC-20 computer system
when possible.

When hypothesis testing was encountered, the 0.05 level

of significance (95% confidence) for type I error was used.

When appro

priate, the descriptive level of significance or P value is given.

This

is defined as the probability of realizing an observed value or a more
extreme value, given that the null hypothesis of equivalence amount models
is true.
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CHAPTER III

RESULTS

Plotted on figure 1 are the average numbers of phagocytosed conidia
per PEC, for each of the

6

models based on microscopic observations of

20 randomly selected PECs per model, plotted vs time in hours.

Note that

the time intervals from time zero, when viable conidia were first intro
duced into each tissue culture plate wells, to the first observed cyto
toxic effects of these PECs on the conidia are also provided.
provides the mean data of these observations from which graph

Table 1
1

was plotted.

Figure 2 provides the plot of the average number of phagocytosed
conidia for each guinea pig model relative to time; however, this graph
portrays only those PECs having actually demonstrated phagocytosis of
conidia.

Those PECs having not phagocytosed any conidia as demonstrated

microscopically by means of the acridine staining procedure, were dropped
from this statistical design.

Table 2 provides the mean data from which

Figure 2 was plotted.
A standard 1-factor, 2-way analysis of variance(46), Table 3, was
computed using the mean data contained in Tables 1 and 2 and other
required parameters, for example, che errors of the means, sums of squares,
F statistics and variances of these sample data necessary in this Anova
design were computed from the raw experimental data.

Computational analysis

was performed through an ANOVA SPSS computer program(41), followed by both
the computation of 4 multiple contrasts and hypotheses testing by this author,
using a hand-held programmable HP-41C calculator.

Since the same relative

statistical results were achieved when using the data from either Table 1
or

2,

(as confirmed through a non-pararoetric statistical process involving
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a modified Chi Square procedure(38) measuring a goodness of fit which
provided a P value of 0.005, which is the probability of a significant
difference between the average data contained in Tables 1 and 2, which
is insignificant), only those data based solely on those PECs containing
intracellular conidia (Table 2) will be used throughout the remainder of
this work.
Based on the 2-factor 1-way ANOVA using the data on Figure 2, two
separate groups of models could be isolated:

the first group, the model

immunized with viable conidia; and the second group, which contained the
other 5 models, which as a unit, were less efficient in antifungal
properties.

It can be seen that the PECs extracted from guinea pigs immu

nized with viable conidia were the most effective of those models tested,
in both their phagocytosing and their fungicidal activity against
ckii.

schen

The probability of this group not being the most efficient and active

phagocytic group studied is less than 0.001.

This group phagocytosed an

average of more than 20 conidia per PEC within the

hour time frame and

8

that intracellular counting of PECs had to be terminated at hour

8

,

because the numbers of intracellular conidia could no longer be accurately
counted, since the PECs were literally "stuffed" with intracellular conidia.
The phagocytic rate between hours 1 and 4 was about 7 conidia per hour,
which was more than double the average rate of any of the other 5 groups.
Intracellular conidia lost viability less than 2 hours after initial
exposure to PECs in this group as demonstrated by the acridine orange
staining procedure.
The non-cortisone compromised animals immunized with non-viable conidia
and the control group were statistically comparable in both fungicidal effects
and phagocytic effects, phagocytosing an average of
respectively within 12 hours.

8

- 7 conidia per PEC

The first fungicidal effects against the

conidia appeared about 4 hours after initial exposure to the PECs.
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Neither phagocytic nor fungicidal activity of PECs from any of the
cortisone compromised animals sensitized with viable conidia differed
significantly from the normal untreated, unsensitized animals.

The phago

cytic efficiency of PECs from the compromised animals challenged with
non-viable conidia was minimal and did not differ significantly from the
unchallenged animals.
appeared

8

The first fungicidal effects against the conidia

hours after initial exposure to the PECs for each of the 3

compromised groups.
Using only one animal from each model for each experimental run
attributed to large internal statistical variations, causing loss in
quantitative precision via the 1-way, 2-factor ANOVA procedure.

To

achieve a greater degree of quantitative resolution through statistical
analysis, a nested ANOVA design(lO) was programmed into the DEC-20
computer system, using the SPSS format.

Unlike the 1-way, 2-factor

ANOVA design, which contrasted the variation of the

6

guinea pig models

to each other based on time, the nested ANOVA design provided a 3-dimen
sional test by comparing the variation among the

6

guinea pig models based

on time with the additional subsample contrast, that of phagocytic varia
tion among PECs, both within each of the
and between each of the

6

6

models (internal variation)

guinea pig models.

Since a statistical sampling

procedure had been violated using the nested ANOVA design in that for each
model, several guinea pigs within that model should have their extracted
PECs pooled, but did not, the P value is significantly high (the probabi
lity of this nested ANOVA design being untrue is P=0.30), which provided a
higher probability of being incorrect than the 2 factor 1 way ANOVA of
P 0.001 does.
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Via the nested design, 3 distinct animal groups, based on phagocytic
efficiency, could be realized using multiple contrast analyses based on
the data contained in the Nested ANOVA Summary table. Table 4.

The most

obvious difference between the 3 groups appeared in the animal model immu
nized with viable conidia.

Within the other 2 models, separated via the

nested design, was the second most efficient phagocytic group consisting
of 3 models:

the normal animal model immunized with non-viable conidia,

the normal control model, and the cortisone compromised model immunized
with viable conidia.

These three models were statistically identical at

the 95% confidence level based on their similar phagocytic efficiency.
The third group isolated and the least efficient of the 3 models included
the two remaining cortisone compromised models, those animals immunized
with non-viable conidia and the cortisone compromised control animals.
The probability of this third group being statistically identical to the
second class in phagocytic efficiency is 0.30.
Of concern in this work was the possible bias effects that both
differences in sex and age might have in this study.

Prior to actually

initiating any of the phagocytic and fungicidal assays as described in
this thesis, a multiple/partial and a partial regression analysis were
performed using the SPSS and BASIC programming formats. .Four experimental
contrasts were devised using a 2 X 2 factorial format similar to those
discussed by Cochran and Cox( 6 ) so as to ensure that each animal model
was both age and sex adjusted.

That is, each model was randomly assigned

1 of 4 variables: an older guinea pig, a younger guinea pig, a female guinea
pig, and a male guinea pig.

Each of these variables was then used one time

within each model during the 4 experimental runs used in completing this
study.

Internal variation within each model was then measured and a
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Partial F Test ANOVA procedure(28) was employed (Table 5), measuring
first the variation explained solely by phagocytic variation due the
treatments which was high (F computed = 19.67).

6

Next the variable,

sex, was measured to find how much additional phagocytic variation
could be explained through this influence.

As can be seen on Table 5,

the additional phagocytic variation explained by sex is negligible (F
computed -> 0.08).
factor tested.

Next the sex variable was removed and the guinea pig

The amount of phagocytic variation explained solely by

age was also negligible (F computed = 0.03).

Finally, both variables,

age and sex, were simultaneously measured to find their joint contribut
ion to explaining phagocytic variation.

Again, the contribution in

explaining additional phagocytic variation was negligible (F computed =

0 .11).
Hence, it can be concluded that sex and the age differences in this
work did not bias the phagocytic results at a probability level of con
fidence of 0.999.
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IV

chapter

DISCUSSION AND CONCLUSIONS

The immunological mechanisms of resistance to the pathogenic fungus
S. schenckii are not fully understood.

According to the literature, the

PEC/fungus relationship is similar to the PEC/bacterium relationship, in
that when conidia or bacteria are encountered in a wound such as a trau
matic implantation within cutaneous tissues, neutrophils play a paramount
antimicrobial role since they are physically present at the wound site
from the onset of the inflammatory process.

Since neutrophils require

no activation to initiate efficient phagocytosis, this phagocytic res
ponse occurs whether or not the animal has been previously immunized
against that foreign body.

In both human mycoses and bacterial infect

ions, neutrophils soon become of lesser phagocytic importance against
those organisms, relative to the activated macrophage, once T-cell secre
tion of lymphokines such as MAP and MIF has occured mainly due to the
lower numbers of neutrophils but higher number of activated macrophages
found in cutaneous tissue.

Also, the physically smaller neutrophil

simply is not capable of phagocytosing the large number of microbial
organisms that the macrophage can.
However, a significant post-phagocytic difference between the bac
terial and fungal models may exist.

Recall that once a bacterial or

fungal cell comes in physical contact with a neutrophil, pseudopodia
from this white blood cell extend and surround the organism, encasing it
within a portion of inverted plasma membrane, the phagosome.

Once the

organism is encased in the phagosome, the entire body, assisted by micro
tubules, moves toward lysosomes(25).

Once the phagosome and lysosomes
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come in physical contact, they fuse, exposing the organism to an environ
ment of low pH, myloperoxidase, hydrogen peroxide, lactoferrin, glycosidases, proteases, lipases, granular cationic proteins, and a halide,
usually iodide.

For the majority of bacteria, the fate is degradation

but this may not be the case with fungi.

Fungi have cell wall structures

significantly different biochemically from either gram negative or posi
tive bacteria.

The fungal cell wall consists mainly of polysaccharide

polymers of cellulose, of chitin, of beta-glucans, and of mannans, either
in combination with each other or appearing as single repeating polymers.
Mammalian PECs are known to lack enzymes capable of degrading these
unique polysaccharide configurations, even after intracellular killing
of these fungi has been demonstrated(7).
fungal bodies may persist intracellularly.

Therefore, the retention of
This may play a significant

role in human resistance to fungal infections since most of the nondegradable fungal cells are partially degraded by phagocytes.

This

partial degradation, however, is at best, slow, hence it may provide an
immunological "boosting" effect by intensifying the immune response.
Some disagreement exists as to whether non-viable fungal antigens
are as immunogenic to a mammalian host as viable fungal antigens.

Howard

(19) reported that immune peritoneal macrophages in both mice and guinea
pigs were activated to a greater extent when immunized with viable H.
capsulatum than with non-viable H. capsulaturn conidia.
have reported similar findings.

Others (13,14,47)

However, using rabbit models, Ferguson

(1 1 ) reported that activation of alveolar macrophages was relatively con
stant regardless of whether viable or non-viable S_^ schenckii were admini
stered as antigens.

Using bacterial models, Mackaness(34) reported that

viable L. monocytogenes were more antigenic than non-viable L . monocytogenes.
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as did others(2>36,37) using various other bacterial models.

It appears

then that both viable fungi and viable bacteria are generally more
antigenic than non-viable types.

From the results of this present work,

it has been demonstrated that viable conidia are more highly antigenic
than non-viable S . schenckii conidia when administered into guinea pigs.
Both the phagocytic rate and the numbers of conidia phagocytosed by PECs of
normal animals immunized with viable conidia were at least twice that of
the PECs from animals immunized with non-viable conidia.

Also, from these

results, it can be seen that both those animals immunized with non-viable
conidia as well as the non-immunized controls were equivalent in phagocytotic ability, which probably means that immunization with non-viable
conidia has no detectable effect on the immune system in terms of PEC
activation.

In the present study, the results obtained through the 2-

factor, 1-way ANOVA statistic, indicate that these
could be separated into

2

6

guinea pig models

groups based on their phagocytic effectiveness.

The most efficient animals in phagocytotic ability were those immunized
with viable conidia.
able from each other.

The other 5 models were statistically indistinguish
The conclusions reached using this statistical

analysis are probably not complete in describing the phagocytic variation
amoung the
subclasses.

5

models contained in group

2

, since it may corsist of

2

separate

With a more sensitive nested ANOVA design, it was determined

that 3 separate classes may exist within the

6

models.

The most effective

phagocytic group consisted of those animals immunized with viable conidia.
The second most effective group consisted of 3 animal models:

control

animals immunized with non-viable conidia; animals compromised with cortisone
and immunized with viable conidia; and animals immunized with non-viable
conidia.

These models were equivalent in phagocytic efficiency.
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and least effective group isolated by this statistical process was
composed of the two cortisone-compromised animal models, those immunized
with non-viable conidia and the non-immunized controls.
Unfortunately this nested design is not above reproach as protrayed
by the relatively low (0.70) probability of being the correct model of
representation, because the requirement for pooling guinea pig PEC samples
within each of the

6

models was not met:

pigs would be required for such a test.

too large a number of guinea
However, the 3 phagocytic group

models appear logical and may be quite valid.
Note that the normal controls and the cortisone-compromised models,
both those immunized with viable conidia and those non-immunized, are
equivalent in phagocytotic efficiency.

Cortisone is known to prevent the

fusion of phagosomes and lysosomes(16) which leads to the inhibition of
enzymatic degradation and alters the plasmalemma inhibiting phagocytosis.
It is also known that cortisone is lymphotoxic and may lead to reduction
in the number of T lymphocytes which are required in PEC activation, as
well as to increased release of neutrophils from the bone marrow into
peripheral blood pools.
It is possible that the cortisone-compromised anamals which were
immunized with viable conidia demonstrated PEC activity equivalent to
the non-immunized control group because immunization with highly antige
nic viable conidia may have compensated for the immune-compromising
effect of cortisone treatments.
Examining the last group,

those models cortisone-compromised and

immunized with non-viable conidia and the non-immunized cortisonecompromised group, it can be argued that there was a more dramatic
repression of the immune response, because this group, based on the
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nested ANOVA design, was least efficient in phagocytosis than the other
model groups.
Using lower levels of cortisone and/or different injection inter
vals might have produced other results.

For example, it was discovered

that a dose of 0.005 mg cortisone per gram animal weight had little
repressive response on the guinea pig immune system, nor did a 0.05 mg
per gram body weight cortisone injection, administered in 3 divided
doses at ten-day intervals.

Conversely, it was found that a 0.05 mg

cortisone per gram body weight injection administered in 7 divided doses
at

2 -day

intervals killed all guines pigs receiving that treatment, per

haps because the animals lost all immunological resistance or suffered
toxic effects of the drug.

Hence the 0.05 mg cortisone per gram body

weight administered in 5 divided doses was found most suitable for this
work.
A significant point in this research was the association between
PEG activation states and cytotoxic activity.

One can see (Fig. 1) that

fungicidal effects occurred with those conidia phagocytosed by the non
cortisone compromised animals and immunized with viable conidia within
half the time required for fungicidal effects to be first noticed in the
non-cortisone compromised animals immunized with non-viable conidia and
the normal controls.

This observation has not previously been reported.

One would, of course, expect the fungicidal effects of the cortisonetreated animals to be reduced for reasons stated above.
Controversy exists as to the role of the humoral immune system in
relationship to mycotic disease.
in most mycotic infections.

Recall that antibodies are produced

Their production of course depends in part

on actual physical contact between fungi and/or fungal metabolites and/
or B lymphocyte recognition of those antigens.
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In the case of acute respiratory infection as in histoplasmosis,
(caused by

capsulatum) detectable IgG, IgM, and IgA immunoglobulins

corresponding to

capsulatum protein and polysaccharide antigens can

be demonstrated from 10-14 days after the initial exposure to the fungus.
Medically, to some extent, the detection of serum antibodies is useful
in determing the status and progress of deep fungal infections, including
human sporotrichosis.
is scarce.

But evidence for direct antibody killing of fungi

Ferguson(ll) however, reported that

schenckii conidial

growth was inhibited by incubating conidia in the presence of antiserum.
Lurie and others(31,33) have demonstrated that S . schenckii conidia and/or
yeast-phase cells are inhibited within the "asteroid body",

an

eosinophilic

immune complex precipitate occurring in histological sections from sporotrichic lesions, and may be converted into "chlamydospores" or (sclerotic
bodies), i.e., thick-walled, non-proliferating cells, in the presence of
increasing immunoglobulin titers.

Also, it has been reported that C.

neoformans has been killed in the presence of anti-cryptococcal antibody.
Also that the C-3 component of complement when activated by ^

albicans,

via the alternate pathway, has been responsible for direct killing of this
fungus.

Others state that beneficial effects of antibody relative to the

host against fungi are inconclusive mainly due to lack of serious study.
Aside from any fungicidal effects immunoglobulins may have upon
fungi, the ability of PECs to phagocytose fungi may be enhanced when
immunoglobulins coat fungal cells opsonizing them for PECs, augmenting
phagocytosis.
It is commonly observed in clinical settings that only low numbers
of fungal elements are normally seen in exudates, tissues, and aspirates
from humans infected with S. schenckii.

Given that human lymphatic phago
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cytes and interstitial cutaneous histiocytes are approximately equal to
the guinea pig PECs in phagocytic effectiveness, the result of the
present work may offer insight into this phenomenon.

Since S. schenckii

antigens are probably ubiquitous in nature, especially on wood products,
it is likely that humans are normally exposed to at least low numbers of
these antigens.

That exposure can often be confirmed via positive skin

tests of persons never having had demonstrable sporotrichosis.

It stands

to reason, then, that immunological memory is present to elicit the
immune response when S. schenckii is encountered in a wound.

The PECs,

of course activated in part by T memory cells, would be highly efficient
in fungal cell killing.

In fact, the observation of low numbers of fungal

elements seen in fixed cutaneous and other localized atypical sporotrichic
infections may be indicative of even more effective activation of human
interstitial histiocytes.

The results of Ferguson(11) indicate that this

concept may reach maxium significance in the alveolar macrophage which are
generally so efficient in conidial killing that pulmonary disease

rarely

occurs in the normal individual.
In the presence of demonstrable antifungal phagocytic activity as
portrayed in this work (or equivalently in humans, the interstitial and
paralymphatic phagocytes) t h : chronicity of sporotrichosis in the presence
of highly efficient phagocytes may be based on the low numbers of normal
or activated phagocytes present in tissues to remove

schenckii com

pletely, and/or the failure of some phagocytes to be activated, possibly
because of reduced immune response to

schenckii antigens actually

present in the infection process due to fungal elements being walled off
in granulomatous lesions and the formation of non-phagocytosing giant cells
by macrophage fusion.
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In sporotrichosis, as caused by traumatic Implantation of S_^ schenckii
Into cutaneous and lymphocutaneous tissues, after about 3 weeks from the
Initial time of fungal Inplantation, a small, hard movable, nontender nodule
appears.

Histological sections reveal this to be a granulomatous lesion

containing fungal debris, walled off by phagocytes, elastic fibers, coll
agenous fibers, and fibrocytes.

This walling off of fungal cells may prevent

B cells from recognizing fungal surface antigens and T cells from receiving
processed Internal, partially degraded, fungal antigens from giant cells,
thus Impairing the Immune response.

In chronic sporotrichic Infections

where the fungal elements multiply faster than they can be phagocytosed,
however, they disseminate through lymphatic vessels, which are normally
sparse In phagocyte numbers, so fungal proliferation may not be Inhibited.
Once these fungi have spread to a lymph node, the majority of fungi sus
pended In the lymph are removed by filtration and phagocytosed by both
granulocytes and monocytes.

Those fungal elements escaping phagocytosis

are free to proliferate Into the subcutaneous tissue and renew this pro
cess over and over until a regional lymph node Is encountered.

Rarely will

S. schenckii escape complete phagocytosis once contained In one of these
nodes.
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CHAPTER V

SUMMARY

Six guinea pig models were treated with ^

schenckii conidia in

various combinations to ascertain the effects of peritoneal exudate cells
(PECs) on these conidia, to find whether or not those PEC effects were
fungicidal or fungistatic to S_^ schenckii conidia, and to determine the
effects cortisone compromise had upon PEC activity.
were measured using these

6

Phagocytic responses

animal models which included animals immu

nized with viable conidia, animals immunized with non-viable conidia,
untreated controls, animals compromised with hydro-cortisone acetate but
not immunized, animals both compromised and immunized with viable conidia
and finally animals both compromised and immunized with non-viable conidia.
Statistical analyses were used to compare the groups.

It appears that

animals immunized with viable conidia are more efficient in clearing these
fungi via phagocytosis, that phagocytic rate and fungicidal properties are
positively correlated, and that cortisone compromise, achieved through
repeated cortisone injections into these animals, reduces both phagocytic
ability and fungicidal properties of PECs.
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